Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Atsunori, Kusakabe"'
Autor:
Shun Ishido, Nobuharu Tamaki, Masayuki Kurosaki, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Toshie Mashiba, Hironori Ochi, Yutaka Yasui, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hideki Fujii, Toru Ishii, Hiroyuki Marusawa, Masahiko Kondo, Atsunori Kusakabe, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Akari Mitsuda, Chikara Ogawa, Hirotaka Arai, Toshimitsu Murohisa, Minoru Uebayashi, Namiki Izumi
Publikováno v:
JGH Open, Vol 7, Iss 6, Pp 424-430 (2023)
Abstract Background and Aim Hepatocellular carcinoma (HCC) surveillance in low‐risk patients (annual incidence
Externí odkaz:
https://doaj.org/article/b64a2bedcc15417daad694e97d928a4c
Autor:
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Sho Matoya, Tomokatsu Miyaki, Yoshihide Kimura, Atsunori Kusakabe, Satoshi Narahara, Takayuki Tokunaga, Katsuya Nagaoka, Keita Kuroyanagi, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Yasuhito Tanaka
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background & Aims Relationships of serum C‐C motif chemokine ligand 5 (CCL5) and C‐X‐C motif chemokine ligand 10 (CXCL10) levels with hot immune features have been reported in patients with hepatocellular carcinoma (HCC). Therefore, we
Externí odkaz:
https://doaj.org/article/62de0767db2a49edbc37c059b963d6d0
Autor:
Hideki Fujii, Hiroyuki Kimura, Chitomi Hasebe, Takehiro Akahane, Takashi Satou, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Hiroyuki Marusawa, Haruhiko Kobashi, Keiji Tsuji, Chikara Ogawa, Yasushi Uchida, Kouji Joko, Akeri Mitsuda, Masayuki Kurosaki, Namiki Izumi
Publikováno v:
JGH Open, Vol 6, Iss 5, Pp 344-352 (2022)
Abstract Background and Aim This study aimed to evaluate the long‐term clinical course of patients achieving a sustained virologic response (SVR) with daclatasvir plus asunaprevir (DCV/ASV) therapy. Methods A total of 911 patients who achieved SVR
Externí odkaz:
https://doaj.org/article/d172c8855d1e460fb110c72802642b83
Autor:
Shintaro Takaki, Masayuki Kurosaki, Nami Mori, Keiji Tsuji, Hironori Ochi, Hiroyuki Marusawa, Shinichiro Nakamura, Toshifumi Tada, Ryoichi Narita, Yasushi Uchida, Takehiro Akahane, Masahiko Kondo, Atsunori Kusakabe, Koichiro Furuta, Haruhiko Kobashi, Hirotaka Arai, Michiko Nonogi, Takashi Tamada, Chitomi Hasebe, Chikara Ogawa, Takashi Sato, Nobuharu Tamaki, Yutaka Yasui, Kaoru Tsuchiya, Namiki Izumi
Publikováno v:
Investigational New Drugs. 41:340-349
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7599b1ec1dd8f9fec918dc6a2bc6acfb
https://doi.org/10.1007/s10637-023-01349-4
https://doi.org/10.1007/s10637-023-01349-4
Autor:
Hironori Ochi, Masayuki Kurosaki, Kouji Joko, Toshie Mashiba, Nobuharu Tamaki, Kaoru Tsuchiya, Hiroyuki Marusawa, Toshifumi Tada, Shinichiro Nakamura, Ryoichi Narita, Yasushi Uchida, Takehiro Akahane, Masahiko Kondo, Nami Mori, Shintaro Takaki, Keiji Tsuji, Atsunori Kusakabe, Koichiro Furuta, Haruhiko Kobashi, Hirotaka Arai, Michiko Nonogi, Takashi Tamada, Chitomi Hasebe, Namiki Izumi
Publikováno v:
Hepatology Research. 53:61-71
We investigated pretreatment neutrophil-to-lymphocyte ratio (NLR) for predicting survival outcomes of atezolizumab plus bevacizumab therapy for hepatocellular carcinoma (HCC) and determined the predictive ability of combined liver reserve-NLR.This re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2308b3cfd8e6e2d594e8792693a11d52
https://doi.org/10.1111/hepr.13836
https://doi.org/10.1111/hepr.13836
Autor:
Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, Hironori Ochi, Yukio Osaki, Yuji Kojima, Ryo Nakata, Tohru Goto, Akahane Takehiro, Hiroyuki Kimura, Akeri Mitsuda, Chiharu Kawanami, Yasushi Uchida, Chikara Ogawa, Atsunori Kusakabe, Ryuichi Narita, Yasushi Ide, Takehiko Abe, Keiji Tsuji, Tadashi Kitamura, Kazuhiko Okada, Tetsuro Sohda, Masaya Shigeno, Takashi Satou, Namiki Izumi
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194704 (2018)
This study aimed to elucidate whether interferon (IFN)-free direct-acting antiviral (DAA) therapy for hepatitis C after curative treatment of hepatocellular carcinoma (HCC) promotes HCC recurrence in a real-world large-scale cohort.This multicenter s
Externí odkaz:
https://doaj.org/article/fa8946d099b443f1b37b8da73dbc579e
Autor:
Takashi Sato, Hiroyuki Kimura, Chikara Ogawa, Hirotaka Arai, Nami Mori, Masayuki Kurosaki, Atsunori Kusakabe, Takehiro Akahane, Kouji Joko, Masahiko Kondo, Chitomi Hasebe, Yasushi Ide, Shinichiro Nakamura, Koichiro Furuta, Toshifumi Tada, Akeri Mitsuda, Namiki Izumi, Hitoshi Yagisawa, Yasushi Uchida, Hiroyuki Marusawa, Haruhiko Kobashi, Yuji Kojima, Ryoichi Narita, Keiji Tsuji
Publikováno v:
Journal of Medical Virology. 93:6247-6256
The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with sofosbuvir (SOF) and velpatasvir (VEL) were assessed in hepatitis C virus (HCV) genotype 1- and 2-infected patients with decompensated cirrho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a82460d15c40a60aa82a873555a688
https://doi.org/10.1002/jmv.27157
https://doi.org/10.1002/jmv.27157
Autor:
Nobuharu Tamaki, Toshifumi Tada, Masayuki Kurosaki, Yutaka Yasui, Hironori Ochi, Toshie Mashiba, Azusa Sakamoto, Hiroyuki Marusawa, Ryoichi Narita, Yasushi Uchida, Takehiro Akahane, Masahiko Kondo, Nami Mori, Shintaro Takaki, Keiji Tsuji, Haruhiko Kobashi, Atsunori Kusakabe, Koichiro Furuta, Hirotaka Arai, Michiko Nonogi, Chikara Ogawa, Takashi Sato, Takashi Tamada, Shinichiro Nakamura, Chitomi Hasebe, Kaoru Tsuchiya, Namiki Izumi
Publikováno v:
Investigational new drugs. 40(6)
Alpha-fetoprotein (AFP) response (relative decline in AFP) is associated with imaging response evaluated by response evaluation criteria in solid tumors ver1.1 (RECIST) and survival in treatment for hepatocellular carcinoma (HCC). However, the optima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bf77de895c2fb8ed239f2b8e64de31
https://pubmed.ncbi.nlm.nih.gov/36152108
https://pubmed.ncbi.nlm.nih.gov/36152108
Autor:
Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, Hironori Ochi, Hiroyuki Marusawa, Yasushi Uchida, Hideki Fujii, Yuji Kojima, Hideo Yoshida, Tohru Goto, Takehiro Akahane, Masahiko Kondo, Keiji Tsuji, Akeri Mitsuda, Chitomi Hasebe, Atsunori Kusakabe, Tetsuro Sohda, Koichiro Furuta, Haruhiko Kobashi, Chikara Ogawa, Yasushi Ide, Hirotaka Arai, Kazuhiko Okada, Masaya Shigeno, Riko Nonogi, Namiki Izumi
Publikováno v:
Journal of viral hepatitisREFERENCES. 29(7)
Improvements in the hepatocellular carcinoma (HCC) recurrence rate and survival have been frequently reported following virus eradication after hepatitis C virus (HCV)-related HCC cure. However, the efficacy of direct-acting antiviral (DAA) therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dfa972abbc013248e9ccfd6e07b9dfa
https://pubmed.ncbi.nlm.nih.gov/35548866
https://pubmed.ncbi.nlm.nih.gov/35548866
Autor:
Sayuki Iijima, Kentaro Matsuura, Tsunamasa Watanabe, Koji Onomoto, Takashi Fujita, Kyoko Ito, Etsuko Iio, Tomokatsu Miyaki, Kei Fujiwara, Noboru Shinkai, Atsunori Kusakabe, Mio Endo, Shunsuke Nojiri, Takashi Joh, Yasuhito Tanaka
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0118000 (2015)
The levels of expression of interferon-stimulated genes (ISGs) in liver are associated with response to treatment with pegylated interferon (PEG-IFN) plus ribavirin (RBV). However, associations between the responses of ISGs to IFN-based therapy and t
Externí odkaz:
https://doaj.org/article/d8197d49c70847a282720b72e5cb697f